TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 21083586

Group type: EXPERIMENTAL
Intervention: MiraLAX/Gatorade
Number of subjects: 190

Group type: COMPARATOR
Intervention: Golytely
Number of subjects: 190

Group type: EXPERIMENTAL
Intervention: Both preparations
Number of subjects: 190
Study: 19957797

Group type: EXPERIMENTAL
Intervention: Heparin treatment group (n = 37)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Routine treatment group (n = 42)
Number of subjects: 79
Study: 17520105

Group type: EXPERIMENTAL
Intervention: Combination therapy of low-dose atorvastatin (5 mg/day) and fenofibrate (160 mg/day)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Atorvastatin (10-40 mg/day)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Fenofibrate (160-200 mg/day)
Number of subjects: 90
Study: 15339323

Group type: EXPERIMENTAL
Intervention: Topical 0.1 n hydrochloric acid
Number of subjects: 120

Group type: COMPARATOR
Intervention: 0.9% saline
Number of subjects: 120
Study: 11336714

Group type: EXPERIMENTAL
Intervention: 400 microg rectal misoprostol in 5 cm(3) of saline
Number of subjects: 663

Group type: COMPARATOR
Intervention: Oxytocin 10 IU, i.m.
Number of subjects: 663
Study: 10758520

Group type: EXPERIMENTAL
Intervention: Subjects with DM and PN
Number of subjects: 34

Group type: COMPARATOR
Intervention: Age-matched comparison group
Number of subjects: 34
Study: 8841866

Group type: EXPERIMENTAL
Intervention: PEEP 5 cmH2O
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: PEEP 10 cmH2O
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: PEEP 15 cmH2O
Number of subjects: 20
Study: 1505536

Group type: EXPERIMENTAL
Intervention: Carbohydrate (CHO) group
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 18
Study: 6393724

Group type: EXPERIMENTAL
Intervention: High-dose betamethasone for 4-5 days
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control group (no steroid treatment)
Number of subjects: 18
Study: 30674279

Group type: EXPERIMENTAL
Intervention: Pain management advice from GP
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Previous experiences of pain medication
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Consultation with GP
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Understanding of pain medication
Number of subjects: 14
Study: 28834103

Group type: EXPERIMENTAL
Intervention: Autologous platelet-rich plasma (PRP) weekly for 6 weeks
Number of subjects: 40

Group type: COMPARATOR
Intervention: Conventional treatment (compression and dressing) for 6 weeks
Number of subjects: 40
Study: 27345218

Group type: EXPERIMENTAL
Intervention: Manual-based psychosexual intervention
Number of subjects: 43

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 43
Study: 24951437

Group type: EXPERIMENTAL
Intervention: Conditioning program (endurance, strength, and motor control training)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Health promotion program (educational sessions)
Number of subjects: 44
Study: 22551551

Group type: EXPERIMENTAL
Intervention: LR17 treatment (early or late)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (treml-1(‐/‐) animals)
Number of subjects: 0
Study: 19663922

Group type: EXPERIMENTAL
Intervention: Glucose (BD Glucose Tablets)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Sucrose (Skittles)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Fructose (Fruit to Go)
Number of subjects: 33
Study: 18591549

Group type: EXPERIMENTAL
Intervention: Cognitive Behavior Therapy (CBT)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 150
Study: 15810049

Group type: EXPERIMENTAL
Intervention: Laparoscopic Roux-en-Y gastric bypass (LRYGBP)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Laparoscopic vertical banded gastroplasty (LVBG)
Number of subjects: 83
Study: 12067003

Group type: EXPERIMENTAL
Intervention: volatile anaesthetics (isoflurane, enflurane, sevoflurane)
Number of subjects: 1180

Group type: EXPERIMENTAL
Intervention: propofol anaesthesia
Number of subjects: 1180

Group type: EXPERIMENTAL
Intervention: postoperative opioids
Number of subjects: 1180

Group type: EXPERIMENTAL
Intervention: being a child
Number of subjects: 1180

Group type: EXPERIMENTAL
Intervention: PONV in the early period
Number of subjects: 1180
Study: 10597985

Group type: EXPERIMENTAL
Intervention: Vitamin A supplementation (single high dose every 4 months)
Number of subjects: 1405

Group type: COMPARATOR
Intervention: Placebo (single high dose every 4 months)
Number of subjects: 1405
Study: 8565034

Group type: EXPERIMENTAL
Intervention: Mepyramine-theophylline-acetate (MTA) 8 mg/kg per day by mouth in three divided doses for 7 days
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo 50 microL/kg per day in three divided doses for 7 days
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Mepyramine-theophylline-acetate (MTA)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 40
Study: 1960549

Group type: EXPERIMENTAL
Intervention: Regional hyperthermic perfusion with melphalan
Number of subjects: 69

Group type: COMPARATOR
Intervention: Surgery (Control)
Number of subjects: 69
Study: 31406997

Group type: EXPERIMENTAL
Intervention: Basal diet with 500 mg/kg resveratrol (HT+Res)
Number of subjects: 288

Group type: COMPARATOR
Intervention: Basal diet (HT)
Number of subjects: 288
Study: 29315807

Group type: EXPERIMENTAL
Intervention: Pictorial icon of Buddha Dipamkara (Buddha of the Past)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pictorial icon of Buddha Maitreya (Buddha of the Future)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Religion prime administered to atheists
Number of subjects: 0
Study: 26892708

Group type: EXPERIMENTAL
Intervention: Two feet-in-the-door technique (preceded by two small requests)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Single foot-in-the-door technique (preceded by one small request)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control condition (only a 24 h stop-smoking request)
Number of subjects: 0
Study: 24625704

Group type: EXPERIMENTAL
Intervention: 1-Hz rTMS over the right dorsolateral prefrontal cortex (intensity of 110% of the threshold; 3000 stimuli per protocol; 10 daily sessions) combined with partial sleep deprivation (PSD applied once per week)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 19
Study: 23171380

Group type: EXPERIMENTAL
Intervention: Rhythm and music-based therapy program
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Therapeutic riding
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group receiving the T1 training program a year later
Number of subjects: 120
Study: 20144164

Group type: EXPERIMENTAL
Intervention: Ivabradine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 17666169

Group type: EXPERIMENTAL
Intervention: Lindgren osteotomy
Number of subjects: 100

Group type: COMPARATOR
Intervention: Distal chevron osteotomy
Number of subjects: 100
Study: 16273564

Group type: EXPERIMENTAL
Intervention: Sirolimus-eluting stents (SES)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Bare-metal stents (BMS)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Sirolimus-eluting stents (SES) in SIRIUS trial
Number of subjects: 51
Study: 11902152

Group type: EXPERIMENTAL
Intervention: Prior study of both alternatives in implicit memory tasks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Neither alternative studied
Number of subjects: 0
Study: 9973914

Group type: EXPERIMENTAL
Intervention: iodixanol (Visipaque) 270 mg I/ml
Number of subjects: 128

Group type: COMPARATOR
Intervention: iopamidol (Iopamiron) 300 mg I/ml
Number of subjects: 128
Study: 7752862

Group type: EXPERIMENTAL
Intervention: Increased training via run training (ITRT) for 10 days (100% NT)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Increased training via cross-training (ITCT) for 10 days (100% NT)
Number of subjects: 11
Study: 1689084

Group type: EXPERIMENTAL
Intervention: Epidural administration of endogenous opioids
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intrathecal administration of endogenous opioids
Number of subjects: 0
Study: 7028529

Group type: EXPERIMENTAL
Intervention: Diclofenac sodium (about 75 mg daily)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study: 31525164

Group type: EXPERIMENTAL
Intervention: PVB + PA
Number of subjects: 213

Group type: COMPARATOR
Intervention: PA
Number of subjects: 213
Study: 26799308

Group type: EXPERIMENTAL
Intervention: Attentional retraining using a dot-probe task
Number of subjects: 74

Group type: COMPARATOR
Intervention: Control training condition
Number of subjects: 74
Study: 25986458

Group type: EXPERIMENTAL
Intervention: 7-valent pneumococcal conjugate vaccine (PCV7)
Number of subjects: 497

Group type: EXPERIMENTAL
Intervention: Concomitant prednisolone
Number of subjects: 497
Study: 24519844

Group type: EXPERIMENTAL
Intervention: Subcutaneous drainage (10 Fr drain placed subcutaneously connected to low pressure aspiration reservoir)
Number of subjects: 260

Group type: COMPARATOR
Intervention: No subcutaneous drainage (control group)
Number of subjects: 260

Group type: EXPERIMENTAL
Intervention: Subcutaneous drainage
Number of subjects: 260

Group type: COMPARATOR
Intervention: No subcutaneous drainage
Number of subjects: 260
Study: 21955834

Group type: EXPERIMENTAL
Intervention: 0.1mg/kg hydrocortisone infused over 30min
Number of subjects: 73

Group type: COMPARATOR
Intervention: Saline infused over 30min (placebo)
Number of subjects: 73
Study: 19200278

Group type: EXPERIMENTAL
Intervention: Support programme (self-monitoring, verbal reinforcement, motivation) in addition to exercise programme
Number of subjects: 0

Group type: COMPARATOR
Intervention: Exercise programme only
Number of subjects: 0
Study: 16217662

Group type: EXPERIMENTAL
Intervention: 0.7% dexamethasone‐cyclodextrin eye drop solution applied once daily
Number of subjects: 20

Group type: COMPARATOR
Intervention: 0.1% dexamethasone sodium phosphate eye drops applied three times a day
Number of subjects: 20
Study: 12820919

Group type: EXPERIMENTAL
Intervention: General anesthesia combined with thoracic epidural analgesia (GEA)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Pure general anesthesia (GA)
Number of subjects: 20
Study: 10849244

Group type: EXPERIMENTAL
Intervention: 20 mg zolpidem
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 8651235

Group type: EXPERIMENTAL
Intervention: Self-reported HIV sexual behaviors
Number of subjects: 246

Group type: EXPERIMENTAL
Intervention: Self-reported drug injection behaviors
Number of subjects: 246
Study: 1794742

Group type: EXPERIMENTAL
Intervention: Prednisone (PDN)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Deflazacort (DFC)
Number of subjects: 27
Study: 6137292

Group type: EXPERIMENTAL
Intervention: Surgical treatment
Number of subjects: 780

Group type: COMPARATOR
Intervention: Medical therapy
Number of subjects: 780

Group type: EXPERIMENTAL
Intervention: Surgical treatment (single-vessel disease)
Number of subjects: 780

Group type: COMPARATOR
Intervention: Medical therapy (single-vessel disease)
Number of subjects: 780

Group type: EXPERIMENTAL
Intervention: Surgical treatment (double-vessel disease)
Number of subjects: 780

Group type: COMPARATOR
Intervention: Medical therapy (double-vessel disease)
Number of subjects: 780

Group type: EXPERIMENTAL
Intervention: Surgical treatment (triple-vessel disease)
Number of subjects: 780

Group type: COMPARATOR
Intervention: Medical therapy (triple-vessel disease)
Number of subjects: 780

Group type: EXPERIMENTAL
Intervention: Surgical treatment (ejection fraction ≥ 0.50, single-vessel disease)
Number of subjects: 780

Group type: COMPARATOR
Intervention: Medical therapy (ejection fraction ≥ 0.50, single-vessel disease)
Number of subjects: 780

Group type: EXPERIMENTAL
Intervention: Surgical treatment (ejection fraction ≥ 0.50, double-vessel disease)
Number of subjects: 780

Group type: COMPARATOR
Intervention: Medical therapy (ejection fraction ≥ 0.50, double-vessel disease)
Number of subjects: 780

Group type: EXPERIMENTAL
Intervention: Surgical treatment (ejection fraction ≥ 0.50, triple-vessel disease)
Number of subjects: 780

Group type: COMPARATOR
Intervention: Medical therapy (ejection fraction ≥ 0.50, triple-vessel disease)
Number of subjects: 780

Group type: COMPARATOR
Intervention: Medical treatment (initially assigned)
Number of subjects: 780
Study: 30947751

Group type: EXPERIMENTAL
Intervention: 200 mg iron dextran (Cosmofer)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 200 mg iron sucrose (Venofer)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 200 mg iron isomaltoside (Monofer)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 1000 mg iron isomaltoside (Monofer)
Number of subjects: 40

Group type: COMPARATOR
Intervention: All iron preparations
Number of subjects: 40
Study: 29135863

Group type: EXPERIMENTAL
Intervention: CROS
Number of subjects: 12

Group type: COMPARATOR
Intervention: Bone-Anchored Implants (BAI)
Number of subjects: 12
Study: 25692382

Group type: EXPERIMENTAL
Intervention: Peer leader modeling of healthy coping
Number of subjects: 706

Group type: EXPERIMENTAL
Intervention: Peer leader modeling plus audience involvement to identify trusted adults
Number of subjects: 706

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 706
Study: 23184120

Group type: EXPERIMENTAL
Intervention: 6-month exercise and hypocaloric healthy eating program
Number of subjects: 90
Study: 20825805

Group type: EXPERIMENTAL
Intervention: Phenobarbital (PB) - mean dosage 509 mg
Number of subjects: 44

Group type: COMPARATOR
Intervention: Lorazepam (LZ) - mean dosage 4.2 mg
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Phenobarbital (PB)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Lorazepam (LZ)
Number of subjects: 44
Study: 18286484

Group type: EXPERIMENTAL
Intervention: Proton transfer reaction-mass spectrometry for VOC analysis
Number of subjects: 22

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 22

Group type: COMPARATOR
Intervention: High-risk patients
Number of subjects: 22

Group type: COMPARATOR
Intervention: Posttherapy patients
Number of subjects: 22
Study: 16527398

Group type: EXPERIMENTAL
Intervention: Heat pain stimulation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (rest)
Number of subjects: 0
Study: 15175436

Group type: EXPERIMENTAL
Intervention: FL plus oxaliplatin
Number of subjects: 2246

Group type: COMPARATOR
Intervention: FL alone
Number of subjects: 2246
Study: 11673596

Group type: EXPERIMENTAL
Intervention: Omega-3 long-chain polyunsaturated fatty acids (LC-PUFA) from fish oil supplementation for 3 months
Number of subjects: 36

Group type: COMPARATOR
Intervention: Untreated healthy children (control group)
Number of subjects: 36
Study: 9467701

Group type: EXPERIMENTAL
Intervention: Tailored antihypertensive educational intervention
Number of subjects: 130

Group type: COMPARATOR
Intervention: Control group (nonparticipating hypertensive workers)
Number of subjects: 130
Study: 7964116

Group type: EXPERIMENTAL
Intervention: Bone marrow transplantation (BMT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard therapy
Number of subjects: 0
Study: 3215319

Group type: EXPERIMENTAL
Intervention: Elective procedures
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Emergency procedures
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Overall surgical workload
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Diagnosis of abdominal aortic aneurysm
Number of subjects: 0
Study: 29445029

Group type: EXPERIMENTAL
Intervention: Pantoprazole (IV, 1.6 mg/kg over 4 hours) with Cisplatin (60 mg/m2 × 2 days per cycle)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Cisplatin (60 mg/m2 × 2 days per cycle) without Pantoprazole
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Pantoprazole (IV, 1.6 mg/kg over 4 hours) with Cisplatin
Number of subjects: 12
Study: 27242272

Group type: EXPERIMENTAL
Intervention: Continuous Positive Airway Pressure (CPAP)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham CPAP
Number of subjects: 0
Study: 24726032

Group type: EXPERIMENTAL
Intervention: Ongoing low molecular weight heparin treatment for cancer-associated thrombosis
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cessation of low molecular weight heparin at six months treatment (current licensed practice)
Number of subjects: 0
Study: 22994901

Group type: EXPERIMENTAL
Intervention: 8 mg cyproheptadine (5‐HT antagonist)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 10 mg escitalopram (SSRI)
Number of subjects: 12
Study: 21174254

Group type: EXPERIMENTAL
Intervention: Experimental prosthetic foot with increased flexibility
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Experimental prosthetic foot with decreased flexibility
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Experimental prosthetic foot with greatest flexibility
Number of subjects: 14
Study: 18760120

Group type: EXPERIMENTAL
Intervention: Sodium bicarbonate hydration (NaHCO(3))
Number of subjects: 1307

Group type: COMPARATOR
Intervention: Normal saline (NS) hydration
Number of subjects: 1307
Study: 16615374

Group type: EXPERIMENTAL
Intervention: Lentulo spiral mounted in a slow‐speed handpiece
Number of subjects: 24

Group type: COMPARATOR
Intervention: Hand‐held lentulo spiral
Number of subjects: 24
Study: 14498766

Group type: EXPERIMENTAL
Intervention: Atlizumab (anti-IL-6 receptor antibody)
Number of subjects: 0
Study: 10875526

Group type: EXPERIMENTAL
Intervention: 1,25‐dihydroxy‐cholecalciferol vitamin D (0.25 mcg daily) and calcium (500 mg daily) for 9 months
Number of subjects: 20

Group type: COMPARATOR
Intervention: Observation only (Control group)
Number of subjects: 20
Study: 9170524

Group type: EXPERIMENTAL
Intervention: PFL-therapy (CDDP, 5-FU, and dl-LV)
Number of subjects: 26

Group type: COMPARATOR
Intervention: FL-therapy (5-FU and dl-LV)
Number of subjects: 26
Study: 1437426

Group type: EXPERIMENTAL
Intervention: Mailed poisoning prevention packet (telephone stickers, coupon for syrup of ipecac, cabinet lock, checklist, pamphlets, cover letter)
Number of subjects: 336

Group type: EXPERIMENTAL
Intervention: Mailed poisoning prevention packet
Number of subjects: 336
Study: 3555090

Group type: EXPERIMENTAL
Intervention: Cefazolin
Number of subjects: 16

Group type: COMPARATOR
Intervention: Cefoxitin
Number of subjects: 16

Group type: COMPARATOR
Intervention: Cefotaxime
Number of subjects: 16
Study: 29330008

Group type: EXPERIMENTAL
Intervention: Contingent feedback
Number of subjects: 60

Group type: COMPARATOR
Intervention: Non‐contingent feedback
Number of subjects: 60

Group type: COMPARATOR
Intervention: No feedback
Number of subjects: 60
Study: 26946313

Group type: EXPERIMENTAL
Intervention: Intravenous ascorbic acid infusion (2g administered starting 30 minutes before anesthesia for 2 hours)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo (administered starting 30 minutes before anesthesia for 2 hours)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Intravenous ascorbic acid infusion
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 24792937

Group type: EXPERIMENTAL
Intervention: Cephalexin, 500 mg (every 6 hours for 7 days)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Clindamycin, 300 mg (every 6 hours for 7 days)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Placebo (every 6 hours for 7 days)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Feasibility
Number of subjects: 78
Study: 22981051

Group type: EXPERIMENTAL
Intervention: Acupuncture (one session a week for four weeks)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Zolpidem (10mg every night for four weeks)
Number of subjects: 33
Study: 19568035

Group type: EXPERIMENTAL
Intervention: Whole-body vibration (WBV) at 50 Hz
Number of subjects: 0

Group type: COMPARATOR
Intervention: Whole-body vibration (WBV) at 20 Hz and 35 Hz
Number of subjects: 0

Group type: COMPARATOR
Intervention: No vibration
Number of subjects: 0
Study: 17549014

Group type: EXPERIMENTAL
Intervention: Consensus diagnosis of AOD by independent panel of neuropathologists
Number of subjects: 150

Group type: COMPARATOR
Intervention: Local diagnosis of AOA
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Panel diagnosis of AOD
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: AOD with 1p/19q loss
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: AOD without 1p/19q loss
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: AOA without 1p/19q loss
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Absence of necrosis and presence of endothelial abnormalities
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Patients' age, 1p/19q loss, and necrosis
Number of subjects: 150
Study: 15139775

Group type: EXPERIMENTAL
Intervention: ITF-1697 dose 2 (loading dose 110 microg/kg i.v., infusion 1.0 microg/kg/min for 24 hours)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: ITF-1697 dose 1 (loading dose 55 microg/kg i.v., infusion 0.5 microg/kg/min for 24 hours)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study: 11773939

Group type: EXPERIMENTAL
Intervention: Antihypertensive drug therapy
Number of subjects: 23000

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23000
Study: 9755357

Group type: EXPERIMENTAL
Intervention: Long-term maintenance treatment for recurrent unipolar major depression; specific intervention details not provided.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Continuation treatment of major depression; specific intervention details not provided.
Number of subjects: 0
Study: 7736899

Group type: EXPERIMENTAL
Intervention: Oral glucose tolerance test (OGTT)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Continuous infusion of glucose with model assessment (CIGMA)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Hyperglycaemic clamp (10 mmol/l)
Number of subjects: 16
Study: 2674713

Group type: EXPERIMENTAL
Intervention: Nibbling diet (17 snacks per day)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Three-meal diet (3 meals per day)
Number of subjects: 7
Study: 169104

Group type: EXPERIMENTAL
Intervention: Gentamicin
Number of subjects: 47

Group type: COMPARATOR
Intervention: Aminosidin-polymyxin B combination
Number of subjects: 47
Study: 31177183

Group type: EXPERIMENTAL
Intervention: GOP infusion
Number of subjects: 26

Group type: COMPARATOR
Intervention: Saline infusion
Number of subjects: 26
Study: 27053635

Group type: EXPERIMENTAL
Intervention: Baseline MRI parameters (T2 lesion number, T1 and T2 lesion volumes, corpus callosum (CC), thalamic fraction)
Number of subjects: 177

Group type: EXPERIMENTAL
Intervention: 12-month MRI parameters (Expanded Disability Status Scale (EDSS), number of new or enlarging T2 lesions, CC volume % change)
Number of subjects: 177

Group type: EXPERIMENTAL
Intervention: Composite score from best predictors of SDP
Number of subjects: 177